Agreement on Major Pathological Response in NSCLC Patients Receiving Neoadjuvant Chemotherapy
Annikka Weissferdt, Apar Pataer, Ara A. Vaporciyan, Arlene M. Correa, Boris Sepesi, César A. Moran, Ignacio I. Wistuba, Jack A. Roth, Jitesh B. Shewale, John V. Heymach, Neda Kalhor, Tina Cascone, Wayne L. Hofstetter, J. Jack Lee, Stephen G. Swisher
Topics & Concepts
MedicineChemotherapyNeoadjuvant therapyLung cancerOncologyInternal medicineSurrogate endpointHazard ratioPathologicalClinical endpointRadiologyCancerClinical trialConfidence intervalBreast cancerLung Cancer Diagnosis and TreatmentLung Cancer Research StudiesCancer Immunotherapy and Biomarkers